Optimizing Radiolabeling Amine-Functionalized Silica Nanoparticles Using SarAr-NCS for Applications in Imaging and Radiotherapy
Source abstract
Abstract
Silica nanoparticles functionalized with amine groups and in the size range of approximately 60-94 nm were produced by combining sol-gel processing and emulsion technology. Hexa-aza cage ligand SarAr-NCS was conjugated to the silica nanoparticles and subsequently radiolabeled with a solution of (57)Co(2+)-doped carrier Co(2+). The number of Co(2+) ions bound to the silica particles at pH 7 was used to determine the average number of available SarAr-NCS ligands conjugated to a silica particle. For organically modified silica particles of 94.0 and 59.5 nm diameter, the maximum number of metal binding sites was determined to be 11700 and 3270 sites per particle, respectively. For silica particles (63.5 nm peak diameter) produced using an water-in-oil emulsion, the calculated average was 4480 on the particle surface. The number of SarAr-NCS conjugated on the particles was easily controlled, potentially providing for a range of products for applications in the risk assessment of particles and theranostic imaging or radiotherapy when radiolabeled with a suitable radioisotope such as (64)Cu or (67)Cu.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Mesoporous Materials and Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Center of Excellence in Anti-matter Matter Studies (CAMS), Research School of Physics and Engineering, The Australian National University, Canberra, ACT 0200, Australia
Collider−Accelerator Department, Brookhaven National Laboratory, Upton, New York 11973, United States
References (44)
Show source-provided references
1. Liu Y. · Curr. Cancer Drug Targets · 2011 · 11 · 15610.2174/156800911794328411 ↗
2. He Q. · J. Mater. Chem. · 2011 · 21 · 584510.1039/c0jm03851b ↗
3. Slowing I. I. · Adv. Funct. Mater. · 2007 · 17 · 122510.1002/adfm.200601191 ↗
4. Ab Rahman I. · J. Nanomater. · 2012 · 2012 · 13242410.1155/2012/132424 ↗
5. Barbé C. · Adv. Mater. · 2004 · 16 · 195910.1002/adma.200400771 ↗
6. Sugimoto T. · 200010.1201/9781482269697 ↗
7. Arriagada F. J. · J. Colloid Interface Sci. · 1999 · 211 · 21010.1006/jcis.1998.5985 ↗
8. Osseo-Asare K. · Colloids Surf. · 1990 · 50 · 32110.1016/0166-6622(90)80273-7 ↗
9. Kumar R. · ACS Nano · 2008 · 2 · 44910.1021/nn700370b ↗
10. Kim S. · J. Am. Chem. Soc. · 2007 · 129 · 266910.1021/ja0680257 ↗
11. Bharali D. J. · Proc. Natl. Acad. Sci. U.S.A. · 2005 · 102 · 1153910.1073/pnas.0504926102 ↗
12. Roy I. · Proc. Natl. Acad. Sci. U.S.A. · 2005 · 102 · 27910.1073/pnas.0408039101 ↗
13. Roy I. · J. Am. Chem. Soc. · 2003 · 125 · 786010.1021/ja0343095 ↗
14. Ottenbrite R. M. · J. Am. Ceram. Soc. · 2000 · 83 · 321410.1111/j.1151-2916.2000.tb01709.x ↗
15. Smith S. V. · J. Phys.: Conf. Ser. · 2011 · 262 · 012055
16. Mume E. · Dalton Trans. · 2011 · 40 · 627810.1039/c0dt01499k ↗
17. Huang S. · Chem. Mater. · 2008 · 20 · 537510.1021/cm800248s ↗
18. Di Bartolo N. M. · Dalton Trans. · 2001 · 15 · 230310.1039/b103242a ↗
19. Di Bartolo N. M. · Org. Biomol. Chem. · 2006 · 4 · 335010.1039/b605615f ↗
20. Smith S. V. · Q. J. Nucl. Med. Mol. Imaging · 2008 · 52 · 193
21. Xie G. · Arch. Toxicol. · 2010 · 84 · 18310.1007/s00204-009-0488-x ↗
22. Kumar R. · ACS Nano · 2010 · 4 · 69910.1021/nn901146y ↗
23. Schweitzer A. D. · Int. J. Radiat. Oncol. Biol. Phys. · 2010 · 78 · 149410.1016/j.ijrobp.2010.02.020 ↗
24. Liang S. · J. Radioanal. Nucl. Chem. · 2006 · 269 · 310.1007/s10967-006-0223-5 ↗
25. Cloarec J. P. · Biosens. Bioelectonr. · 2002 · 17 · 40510.1016/S0956-5663(01)00282-2 ↗
26. Davis M. E. · Nat. Rev. Drug Discov. · 2008 · 7 · 77110.1038/nrd2614 ↗
27. Litzinger D. C. · Biochim. Biophys. Acta · 1994 · 1190 · 9910.1016/0005-2736(94)90038-8 ↗
28. Nomura T. · Pharm. Res. · 1998 · 15 · 12810.1023/A:1011921324952 ↗
29. Ishida O. · Int. J. Pharm. · 1999 · 190 · 4910.1016/S0378-5173(99)00256-2 ↗
30. Garnett M. C. · MRS Bull. · 1999 · 24 · 4910.1557/S0883769400052325 ↗
31. Hu-Lieskovan S. · Cancer Res. · 2005 · 65 · 898410.1158/0008-5472.CAN-05-0565 ↗
32. Mume, E.; Asad, A.; Di Bartolo, N. M.; Kong, L.; Smith, C.; Sargeson, A. M.; Price, R.; Smith, S. V.Synthesis of Hexa Aza Cages, SarAr-NCS and AmBaSar; Metal Complexation, Conjugation to Nanomaterials and Proteins for Application in Radioimaging and Therapy. Unpublished data.
33. Wang A. Z. · Ann. Rev. Med. · 2012 · 63 · 18510.1146/annurev-med-040210-162544 ↗
34. Steichen S. D. · Eur. Pharm. Sci. · 2013 · 48 · 41610.1016/j.ejps.2012.12.006 ↗
35. Brannon-Peppas L. · Adv. Drug Delivery Rev. · 2012 · 64 · 20610.1016/j.addr.2012.09.033 ↗
36. Cheng Z. · Science · 2012 · 338 · 90310.1126/science.1226338 ↗
37. Ahmed N. · Drug Discov. Today · 2012 · 17 · 92810.1016/j.drudis.2012.03.010 ↗
38. Sailor M. J. · Adv. Mater. · 2012 · 24 · 377910.1002/adma.201200653 ↗
39. Werner M. E. · Curr. Pharm. Design · 2012 · 18 · 283010.2174/138161212800626229 ↗
40. Li Z. · Chem. Soc. Rev. · 2012 · 41 · 259010.1039/c1cs15246g ↗
41. Yiu H. H. P. · Adv. Funct. Mater. · 2010 · 20 · 159910.1002/adfm.200902117 ↗
42. Allard E. · J. Polym. Sci., Part A · 2008 · 46 · 620610.1002/pola.22931 ↗
43. Sing K. S. W. · Pure Appl. Chem. · 1985 · 57 · 60310.1351/pac198557040603 ↗
44. Finnie K. S. · J. Sol-Gel Sci. Technol. · 2009 · 49 · 1210.1007/s10971-008-1847-4 ↗